Esculentin 1a derivatives and uses thereof
View Patent ↗Provided herein are synthetic antibacterial peptides that have a sequence at least 80% identical to a sequence shown in SEQ ID NO: 2 or the diastereomer thereof with a sequence shown in SEQ ID NO: 3 or pharmaceutical compositions thereof. Also provided are methods for stimulating wound healing via the synthetic antibacterial peptides and for forming an antimicrobial coating on contact lenses. In addition a device is provided that has a surface with a coating of the synthetic antibacterial peptides.
1. A method for stimulating wound healing, comprising the step of contacting a wound with an antimicrobial component comprising an antibacterial peptide with a sequence at least 80% identical to the sequence of SEQ ID NO: 2 or a diastereomer thereof with a sequence at least 80% identical to the sequence of SEQ ID NO: 3.
2. The method of claim 1 , wherein the step of contacting the wound with the antimicrobial component induces closure of the wound.
3. The method of claim 1 , wherein the step of contacting the wound with the antimicrobial component comprises complete coverage of the wound with the antimicrobial component.
4. The method of claim 1 , wherein the antimicrobial component is in the form of a solid, an ointment, a gel, a liquid, an aerosol, a mist, a polymer, a film, an emulsion, or a suspension.
5. The method of claim 1 , wherein the antimicrobial component further comprises a sustained-release carrier.
6. The method of claim 5 , wherein the sustained-release carrier is a sustained release polymer, a nanoparticle, a nanosuspension, a liposome or a microcapsule.
7. The method of claim 1 , wherein the antimicrobial component comprises the antibacterial peptide in a concentration of 0.005 μM to 256 μM.
8. The method of claim 1 , wherein the wound is contacted with the antimicrobial component for a period of time between three hours and twenty-four hours.